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Introduction
 The global incidence of breast cancer in women is 
alarmingly high and still increasing in both developing 
and developed countries. Carcinogenesis could be 
simplified into three main stages; initiation, promotion 
and progression (Barrett, 1993) and each step is believed 
to happen over a long period of time. As such there is a 
possibility that multiple steps involved in carcinogenesis 
could be intervened or modulated with chemo-preventive 
agents. For a common cancer prevention study, potential 
agents which could be used are given either before or 
shortly after the carcinogen exposure (Mehta, 2000). 
 Honey is known for centuries for its medicinal and 
health promoting properties. Honey is produced from 
complex enzymatic process of nectar and saccharine 
exudates collected from various kinds of floral sources 
(Ball, 2007). It contains various kinds of phytochemicals 
with high phenolic and flavonoids content which 
contribute to its high antioxidant activity (Yao et al., 
2003; Iurlina et al., 2009; Pyrzynska and Biesaga, 2009). 
Agent that has strong antioxidant property may have the 
potential to prevent development of cancer (Valko et al., 
2007). Phytochemicals available in honey can be narrowed 
down into phenolic acids and polyphenols. Variants of 
polyphenols in honey are reported to have antiproliferative 
property against several types of cancer (Jaganathan and 
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Mahitosh, 2009). 
 Tualang Honey (TH) is a wild jungle honey produced 
by Apis dorsata bees which make hives on tall Kompassia 
excelsa (Tualang) trees of tropical rainforests (Tan et 
al., 2009; Nasir et al., 2010). TH is reported to have 
antiproliferative effect against oral cancer osteosarcoma 
cell lines (Ghashm et al., 2010). The aim of this study 
was to evaluate the effects of Malaysian jungle Tualang 
Honey (AgroMas™) in modulating the development of 
breast cancer induced by 7,12-dimethylbenz(α)anthracene 
(DMBA) in rats. This is a preliminary in vivo study of the 
effect of honey on induced breast cancer in rats.
 
Materials and Methods
Animals
 Forty female Sprague-Dawley rats aged between 45 to 
48 days old were used. The animals were purchased from 
Laboratory Animal Research Unit USM (LARUSM) and 
were acclimatized for a week prior to induction. Animals 
were housed individually in a polycarbonate cage and 
maintained on a 12 hour light/dark cycle at 24±2°C. 
Animals were provided with food pellets and reverse 
osmosis water ad libitum. 
Chemicals and honey
 All chemicals used in this study were of analytical 
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grade. DMBA was purchased from Sigma-Aldrich Co., St. 
Louis, MO. Tualang Honey (AgroMas™) was provided 
by FAMA (Federal Agricultural Marketing Authority), 
Ministry of Agriculture and Agro-based Industry, 
Malaysia. The honey samples were filtrated, evaporated at 
400C (to achieve 20% water content) and were subjected to 
gamma irradiation at 25 kGy for sterilization by STERILE 
GAMA™, Selangor.
Study design
 The research protocol of the study was approved 
by Universiti Sains Malaysia Animal Research Ethic 
Committee [USM/Animal Ethics Approval/2008/(33)
(111)]. After an approximately 18 hours of fasting, rats 
were given 80 mg/kg DMBA via oral gavaging. Rats were 
randomized into four groups with ten animals per group 
(n=10). Animals in Group 1 were given only distilled water 
(vehicle) and used as Control, whereas Group 2, 3 and 
4 were administered with 0.2, 1.0 and 2.0 g/kg Tualang 
Honey diluted in 0.5 ml distilled water respectively given 
via oral gavage daily for 150 days. 
 The rat breast tissue areas were palpated twice weekly 
to detect the appearance of breast tumour masses and for 
monitoring their progression. Once a mass in the breast 
pad was detected, its size and location were recorded. 
After 150 days of treatment, animals were sacrificed 
after intraperitoneal injection of 70-100 mg/kg ketamine. 
Tumor masses were examined in vivo then excised, rinsed 
in phosphate buffered saline (PBS), individually weighed 
and measurement taken as per published protocol (Lai 
and Singh, 2006). One half of each cancer was fixed in 
neutral buffered formalin for histological analysis while 
the other half was kept at -80°C for vascular endothelial 
growth factor (VEGF) assay.
Histopathological examination of the breast cancers
 The breast tumour specimens were fixed in buffered 
formalin. Once fixed, they were blocked, sections and 
stained with hematoxylin and eosin using the standard 
method. The stained sections were examined under light 
microscope at 100x, 200x and 400x magnification using 
Olympus BX41 microscope (Olympus Optical Co. Ltd., 
Tokyo, Japan). The tissue sections were examined by a 
pathologist (NHO, corresponding author) who was blind 
to the treatment received by the rats. The cancers were 
graded as per human cancers grading system using the 
modified Bloom and Richardson as stated by published 
study (Mukhopadhyay et al., 2006). 
Detection of apoptotic cells by TUNEL assay 
 Terminal deoxynucleotidyl transferase (TdT)-mediated 
dUTP nick end labeling (TUNEL) assay was carried out 
using Roche© In Situ Cell Death Detection Kit, POD 
(Roche Applied Science, Mannheim, Germany) according 
to the manufacturer’s instructions. Sections were 
examined under Olympus BX41 microscope (Olympus 
Optical Co. Ltd., Tokyo, Japan). The apoptotic cells were 
counted from ten randomly-selected fields under 400x 
magnification. Apoptotic index (AI) was determined by 
calculating the amount of TUNEL positive cells over total 
number of cells counted.
VEGF level analysis
 Breast cancers were weighed, minced and homogenized 
in 5 volume of ice-cold extraction buffer of 50 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1 mM PMSF 
and EDTA-free protease inhibitor cocktail tablets by 
using Ultra-Turrax T25 basic (IKA®, Staufen, Germany) 
disperser. The homogenates were centrifuged at 10,000 
g for 15 minutes at 4°C. Supernatants were collected and 
used for protein quantification and ELISA. Total protein 
concentration was measured using BCA protein assay kit 
(Pierce Biotechnology, Rockford, IL, USA). The amount 
of VEGF in the supernatant was measured using rat VEGF 
ELISA kit for tissue lysate (RayBiotech, Inc., Norcross, 
Georgia, USA) according to manufacturer’s instructions. 
All tissue lysate were diluted 1:40 in sample diluents. 
Mean absorbance was obtained to quantify mean VEGF 
concentration of the Control and Test (treatment) samples. 
 
Statistical analysis
 Comparisons between mean values of Control and 
Test (treatment) groups were analyzed using one-way 
ANOVA with post-hoc test of Tukey Honest Significance 
Differences (Tukey’s HSD). Comparisons of median 
values between several groups were done using Kruskal-
Wallis and between two groups by Mann-Whitney U test. 
Data was considered significantly different when p value 
was less than 0.05 (p<0.05). 
Results 
The morphology of the cancers in general
 Of the 40 rats which were recruited, a total of 31 rats 
completed the study. The 9 rats which did not complete 
the study died due to various causes and were excluded 
from analysis. All rats in the Tualang honey treatment 
group had significant less body weight gain. There were 
a total of 43 tumour nodules noted in these 31 rats (a few 
rats had more than one tumour nodule). The rats in the 
Control group had earlier tumour development compared 
with TH-treated rats and showed significant increment of 
tumour size over shorter period of time with the largest 
size reaching 8 cm3 (Figure 1). Tumour masses in TH-
treated groups had slower size increment and had lesser 
mean size (≤2 cm3) (Table 1). In terms of the number of 
tumour masses developed, Control rats had more number 
of tumour nodules (tumor multiplicity) (Table 1). The 
medians weights (g) and volumes (cm3) of the tumour 
Figure 1. The Size of Cancer (in cm3) Measured Against 
Time Taken (in weeks) after DMBA Induction. Data is 
presented as mean±SEM. TH=Tualang Honey
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masses in all TH-treated groups were significantly lower 
(p<0.05) compared to Control (Table 1).
 The vasculature around the tumour nodules was more 
prominent in the Control group compared with honey 
treated groups (Figure 2A). The tumours were also larger 
in size, firmer in consistency, more solid while in honey-
treated groups were generally smaller, softer and paler 
with spots of necrosis (Figure 2B) and in some cases 
resembled normal structure of breast tissue. 
The histology of the tumour masses
 Five of the 43 tumour nodules showed benign 
histology and were not included in the analysis. The rest 
of the nodules showed invasive ductal adenocarcinoma 
with varying degree of Ductal Carcinoma in situ (DCIS) 
component. The cancers in the Control group showed more 
pleomorphic cells with more prominent nuclei. The mitotic 
figures were numerous and scattered throughout the tissue 
sections. In areas the cells were vacuolated and showed 
degenerative changes (Figure 2C). In contrast, cancer cells 
from the TH-treated groups were more uniformed in size 
and shape and had denser nuclei (Figure 2C). There were 
also presence of moderate to high number of inflammatory 
cells, mainly lymphocytes, plasma cells and eosinophils 
(Figure 2C-G3).
 Majority of the cancers in the Control group showed 
high grade while cancers in honey-treated groups were 
of medium or low grade (Table 2). Ductal cancer in situ 
(DCIS) was observed both in Control and in TH-treated 
groups (less than 5%). 
Apoptotic index
 There was an increasing trend of apoptotic index 
(AI) seen in TH-treated groups with increasing dosage of 
Tualang Honey (Figure 3), however, the mean AI values 
of all TH-treated groups were not significantly different 
from the Control (p>0.05).
VEGF level as determinant for angiogenesis
 Median values of VEGF protein expression level in 
all TH-treated groups were seen lower than Control group 
(32.81, IqR 33.65 pg/mg protein). The difference between 
the groups was not statistically significant (p>0.05) (Table 
3).
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Table 1. The Characteristics of the Breast Cancers 
in Rats after DMBA Administration in Control and 
Tualang Honey (TH) Treated Groups
 Group 1 Group 2 Group 3 Group 4
 (Control) (0.2g/kgTH) (1.0g/kgTH) (2.0g/kgTH)
No. of rats
 9.00 8.00 7.00 7.00
Day when first palpable tumor was detected#
 106.00±9 127.00±8 140.00±4 101.00±18
Average % of rat body weight gain**
 126.36±8.24  88.11±8.12* 91.58±7.04*  97.24±10.50* 
No of cancers developed
 14.00 12.00 5.00* 7.00*
Weight of cancer mass (g)
 1.07 (5.15) 0.18 (0.28)* 0.12 (1.12)* 0.16 (0.24)*
Volume of cancer mass (cm3)
 1.23 (6.26) 0.19 (0.45)* 0.09 (1.08)* 0.06 (0.16)*
*Statistically significant against Control (p<0.05). **Inclusive of weight of 
cancerous mass. #Data is presented as mean±SEM
Figure 2. Grid Showing the Gross Morphology and the Histology of the Breast Cancers in Rats Developed after 
DMBA Administration in Control and Tualang Honey (TH) Treated Groups
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
Table 2. The Grading of Breast Cancers Developed 
after DMBA Administration in Control and Tualang 
Honey (TH) Treated Groups
Groups No. of Cancers Tumor grade*
 1  (%) 2  (%) 3  (%)
1 (Control) 14 1(7.1) 4(28.6) 9(64.3)
2 (0.2 g/kg TH) 12 5(41.6) 6(50.0) 1(8.3)
3 (1.0 g/kg TH) 5 1(20.0) 2(40.0) 2(40.0)
4 (2.0 g/kg TH) 7 1(14.3) 6(85.7) 0(0)
*Based on modified Bloom and Richardson grading system
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Discussion
This preliminary study shows honey had some effect 
in modulating breast cancer development induced by 
DMBA. The cancers in the Control rats had significant 
rapid growth and attained bigger size compared to those 
in the honey-treated groups (Figure 1). Histology showed 
majority of the cancer cells in the Control group were of 
higher grade, had more mitotic activities and were more 
pleomorphic in nuclear size. The vasculature of the cancers 
in the Control was also more prominent than those in 
honey-treated cancers. This study supports the findings of 
previous study where Tualang honey was shown to have 
anti-proliferative effect when tested against oral squamous 
cell cancers and human osteosarcoma cell lines (Ghashm 
et al., 2010).
TH seems to have the ability to modulate carcinogenic 
effect of DMBA induction as we noted the tumour nodules 
developed later than seen in Control rats. The nodules 
were smaller in size and in some rats became impalpable 
with time. All the benign breast lesions we observed were 
in the honey-treated groups. We also noted lesser number 
of tumour nodules developed in these rats. This is an 
interesting observation implying TH has the potential to 
be used as an agent to modulate cancer development in 
persons who are exposed to carcinogens. TH has been 
shown to have significant anticancer effect against human 
breast and cervical cancer cell lines due to induction 
of apoptosis (Fauzi et al., 2010). The lesser number of 
cancers could also be explained due to ability of honey 
in controlling metastasis (Gribel and Pashinskii, 1990). 
This could be related to presence of caffeic acid phenyl 
ester (CAPE) that can be largely found in honey. CAPE is 
a strong antimetastatic agent specialized in inhibition of 
invasive potential of malignant cells (Hwang et al., 2006).
The anti-promoting activity might be related to the 
strong antioxidant activity in TH as shown by the high total 
phenolic content and total antioxidant activity from ferric 
reducing ability of plasma (FRAP) assay of Tualang honey 
(Mohamed et al., 2010). Various polyphenols constituents 
in honey can also be connected to the anticancer property. 
Among wide range of polyphenolic compounds found in 
honey, only several compounds were identified for the 
antiproliferative property such as caffeic acid, caffeic 
acid phenyl ester, chrysin, galangin, quercetin, acacetin, 
kaempferol, pinocembrin, pinobanksin and apigenin 
(Jaganathan and Mahitosh, 2009). Quercetin was proven 
to inhibit breast cancer growth in mice by exerting 
antiproliferative effect against MCF-7 breast cancer cell 
line (Indap et al., 2006) and apigenin had antiproliferative 
effect against HER2/neu-overexpressing cells (Way et 
al., 2004).
Skeptics will argue on the beneficial effect of honey 
as anti-cancer modulating agent as honey is essentially 
rich in carbohydrates. It also has small amount of lipids 
(Ball, 2007). Carbohydrates in honey are in concentrated 
form which could yield huge amount of calories per small 
quantity of honey. High calorie diet could initiate breast 
cancer formation and promotes cancer development 
(Kritchevsky et al., 1984; Welsh, 1994). However, the 
high caloric amount in TH did not cause major influence 
on the bodyweight of the animals in our study. We are 
currently investigating on why the sugars in honey are 
not carcinogenic. 
Application of histological grading in assessing cancer 
of the breast is crucial for prognosis and predicting the 
post-treatment survival (Harvey et al., 1995; Dalton et al., 
2000). The cancers in TH-treated groups were of better 
grade than in Control indicating the possibility of honey 
in controlling the behavior of the tumor at cellular level. 
Of the three criteria used in histological grading, mitotic 
count is considered the most accurate and significant in 
predicting the clinical outcome (Volpi et al., 2004). 
DCIS is a form of early cancer and it is often detected 
at mammography (Silverstein, 1998). DCIS is claimed 
to be the precursor of invasive breast cancer as both type 
shares the same biological characteristics (Burstein et 
al., 2004). We noted DCIS was present in both honey 
and Control groups. Such observation was also made on 
previous studies on DMBA-induced breast cancer model 
(Dias et al., 1999; Russo and Russo, 2000; Costa et al., 
2002). 
We observed the apoptotic index is high in TH-treated 
cancers (Figure 3). Several polyphenols constituents 
in honey have been studied for the apoptotic property. 
Chrysin is able to induce apoptosis through activation of 
caspase-3 and Akt signal pathway in U937 cancer cell lines 
Figure 3. Percentage of Apoptotic Cells Per Total 
Number of Cells Counted (Apoptotic index, AI) (Group 
1=Control, Group 2=0.2 g/kg/day TH, Group 3=1.0 
g/kg/day TH, Group 4=2.0 g/kg/day TH). TH=Tualang 
Honey. Top Insert- arrows showing apoptotic cells
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Table 3. The Concentration of VEGF Protein (pg/
mg total protein) of Breast Cancers Developed after 
DMBA Administration in Control and Tualang Honey 
(TH) Treated Groups
 Groups P value
 1 2 3 4
 (Control) (0.2**) (1.0**) (2.0**)
VEGF level (pg/mg protein)
 32.81 (33.65) 10.18 (38.28) 17.61 (0) 5.16 (0) 0.704
*Data is presented as median and interquartile range (IqR). **g/kg TH
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(Woo et al., 2004). Flavonoid type acacetin is capable of 
inducing apoptosis in non-small cell lung cancer and liver 
cancer cell lines (Hsu et al., 2004a; 2004b). We however 
did not determine which polyphenols are responsible for 
apoptosis in our study. 
In rats, angiogenesis is usually found in neoplastic 
epithelium rather than in normal epithelium (Maiorana 
and Gullino, 1978). Pro-angiogenic VEGF is the most 
significant tumor-derived factor as it modulates activation, 
migration and proliferation of endothelial cells (Makrilia 
et al., 2009). In human with primary breast cancer, it is 
claimed that VEGF is produced in the cytoplasm of the 
tumor cells (Toi et al., 1996). As such it is more accurate 
to measure angiogenic activity directly from the cancer 
tissue rather than measuring the circulating VEGF 
from the serum. VEGF is also capable to determine 
the aggressiveness of DCIS since DCIS can elicit new 
vascularization (Tosetti et al., 2002). We found the 
concentration of VEGF protein measured from tumor 
tissue lysate in the Control rats was higher compared 
to TH-treated cancers affirming its role in promoting 
angiogenesis as depicted by increased tumor vasculature.
Necrotic spots seen in cancers are due to inadequate 
supply of oxygen as cancer cells grow more rapidly than 
normal cells. Hypoxia can trigger the release of multiple 
angiogenic factors including VEGF, platelet-derived 
growth factor (PDGF) and tumor necrosis factor-α 
(TNF-α) (Makrilia et al., 2009). This would further 
increase the amount of VEGF thus neovascularization 
activity. Regressing size of tumors in DMBA-induced 
rats has been shown to have lower capacity of angiogenic 
response (Maiorana and Gullino, 1978). 
The limitation of our study is in the number of rats 
which completed the study period of 150 days; only 
31 of the 40 rats induced by DMBA as 9 rats died of 
various causes. The number of tumour nodules developed 
(43) somewhat compensated for this limitation. We are 
currently working on a larger number of rats per group 
using different method of breast cancer induction.
In conclusions, daily Tualang honey consumption 
continuously for 150 days starting a day after DMBA 
administration was positively modulating the progression 
of DMBA-induced breast cancer in rats. Cancers of honey-
treated rats were much less in number, volume and weight 
with better histological grade and morphology compared 
to non-honey treated rats. Apoptotic activity was also 
higher with increasing honey concentration and reduced 
level of angiogenesis was observed. The results suggest 
that Tualang honey might have the potential to be used as 
a prophylactic or therapeutic agent to combat growth of 
breast cancer or as adjuvant to conventional chemotherapy. 
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